BlossomHill Therapeutics, a biotech company focused on the field of oncology, plans to raise approximately $132.8 million through an initial public offering.

Zhitongcaijing · 2d ago
BlossomHill Therapeutics, a biotech company focused on the field of oncology, plans to raise approximately $132.8 million through an initial public offering.